In conjunction with data reported in the current paper we would expect that ghrelin administration could also mitigate the neuro-inflammatory events activated following brain hemorrhage–neuroinflammation, which is a challenge to diagnose and manage [35]. The gene discussed is GHRL; the disease is intracranial hemorrhage.